Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.

Definition

A lysosomal storage disease associated with a combined deficiency of beta-galactosidase and neuraminidase, secondary to a defect in cathepsin A. All patients have clinical manifestations typical of a lysosomal disorder, such as coarse facies, cherry red spots, vertebral changes, foam cells in the bone marrow, and vacuolated lymphocytes. Three phenotypic subtypes are recognized. The early infantile form is associated with fetal hydrops, edema, ascites, visceromegaly, skeletal dysplasia, and early death. The late infantile type is characterized by hepatosplenomegaly, growth retardation, cardiac involvement, and a normal or mildly affected mental state. The juvenile/adult form is characterized by myoclonus, ataxia, angiokeratoma, mental retardation, neurologic deterioration, absence of visceromegaly, and long survival.

Acronym

GSL

Synonyms

Cathepsin A deficiency
Goldberg syndrome
Lysosomal protective protein deficiency
Neuraminidase deficiency with beta-galactosidase deficiency
PPCA deficiency
Protective protein cathepsin A deficiency